Proteome Sciences Plc ("Proteome Sciences", or "the Company") announces that the Board has approved the appointment of Cooper Parry Group Limited (Cooper Parry) as the Group's new external auditor, and that BDO LLP ("BDO") has resigned as the Group's auditor.
The Board of Proteome Sciences plc is pleased to announce that Abdelghani Omari has been appointed as the Company’s new Chief Financial Officer. He will take up the position on September 1st, 2022 and will become a director of the Company.
Proteome Sciences plc is pleased to announce that Chief Executive Officer, Dr Mariola Soehngen, will provide a live presentation relating to Interim Results via the Investor Meet Company platform on 18th August 2022 at 10:30am BST.
Proteome Sciences announces its unaudited interim results for the six months ended 30 June 2022.
Proteome Sciences is pleased to announce that the Company has completed the next milestone towards the launch of Single Cell Proteomics services, which will be known as SysQuant® SCP, with the installation of a cellenONE® (Cellenion, France) platform that allows the semi-automated preparation of up to 2,700 cells per week.
The directors of Proteome Sciences announce that the Company’s registered office address has changed to Coveham House, Downside Bridge Road, Cobham, Surrey KT11 3EP with immediate effect.
The directors of Proteome Sciences are pleased to announce that at the Company's AGM, held at 12.00 p.m. today, all resolutions were duly passed.
Annual General Meeting (AGM) Statement